Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection
- PMID: 2410106
Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection
Abstract
A high correlation was found among antibodies to human T-cell leukemia virus type III (HTLV-III), acquired immunodeficiency syndrome, and acquired immunodeficiency syndrome-related complex. With the Western blot technique the antigens (shown as proteins with molecular weights given in thousands) in HTLV-III lysates recognized by positive sera have been identified as p120, p66, p51, p41, p31, p24, and p17. The most common reactivity was toward p41. Lectin fractionation identified p120 and p41 as glycoproteins. Studies using mouse monoclonal antibodies to the p24 proteins of HTLV-I, -II, and -III showed that HTLV-I and -II have common epitopes in p24 molecule, but these are not the cross-reactive epitopes present on HTLV-III p24.
Similar articles
-
Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972).Cancer Res. 1985 Sep;45(9 Suppl):4624s-4626s. Cancer Res. 1985. PMID: 2990697
-
HTLV-III: the etiologic agent of AIDS.Princess Takamatsu Symp. 1984;15:301-8. Princess Takamatsu Symp. 1984. PMID: 6100648
-
Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.Cancer Res. 1985 Sep;45(9 Suppl):4534s-4538s. Cancer Res. 1985. PMID: 2990682 Review.
-
Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).Cancer Res. 1985 Sep;45(9 Suppl):4694s-4699s. Cancer Res. 1985. PMID: 2410115 Review.
-
Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.J Immunol. 1987 Feb 15;138(4):1064-7. J Immunol. 1987. PMID: 3027168
Cited by
-
Selective alterations in immunoregulatory lymphocyte subsets in early HIV (human T-lymphotropic virus type III/lymphadenopathy-associated virus) infection.J Clin Immunol. 1987 Mar;7(2):140-50. doi: 10.1007/BF00916008. J Clin Immunol. 1987. PMID: 2883197
-
Immunology of HIV infection and AIDS: memorandum from a WHO/IUIS meeting.Bull World Health Organ. 1987;65(4):453-63. Bull World Health Organ. 1987. PMID: 3319268 Free PMC article. Review.
-
Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind study.J Clin Immunol. 1988 Nov;8(6):464-72. doi: 10.1007/BF00916952. J Clin Immunol. 1988. PMID: 3146584
-
Characterization of monoclonal antibodies directed against distinct conserved epitopes of human immunodeficiency virus type 1 core proteins.Mol Cell Biochem. 1990 Aug 10;96(2):127-36. doi: 10.1007/BF00420904. Mol Cell Biochem. 1990. PMID: 1703272
-
Comparison of immunoblots with neutralizing and complement fixing antibodies in experimental and natural cases of visna-maedi.Arch Virol. 1992;123(1-2):47-58. doi: 10.1007/BF01317137. Arch Virol. 1992. PMID: 1550497
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical